1. Home
  2. VKTX vs CNM Comparison

VKTX vs CNM Comparison

Compare VKTX & CNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • CNM
  • Stock Information
  • Founded
  • VKTX 2012
  • CNM 1996
  • Country
  • VKTX United States
  • CNM United States
  • Employees
  • VKTX N/A
  • CNM N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • CNM Durable Goods
  • Sector
  • VKTX Health Care
  • CNM Consumer Discretionary
  • Exchange
  • VKTX Nasdaq
  • CNM Nasdaq
  • Market Cap
  • VKTX 4.7B
  • CNM 9.7B
  • IPO Year
  • VKTX 2015
  • CNM 2021
  • Fundamental
  • Price
  • VKTX $41.49
  • CNM $51.35
  • Analyst Decision
  • VKTX Strong Buy
  • CNM Buy
  • Analyst Count
  • VKTX 12
  • CNM 10
  • Target Price
  • VKTX $106.75
  • CNM $57.30
  • AVG Volume (30 Days)
  • VKTX 3.6M
  • CNM 2.7M
  • Earning Date
  • VKTX 02-05-2025
  • CNM 12-03-2024
  • Dividend Yield
  • VKTX N/A
  • CNM N/A
  • EPS Growth
  • VKTX N/A
  • CNM 0.85
  • EPS
  • VKTX N/A
  • CNM 2.11
  • Revenue
  • VKTX N/A
  • CNM $7,183,000,000.00
  • Revenue This Year
  • VKTX N/A
  • CNM $12.91
  • Revenue Next Year
  • VKTX N/A
  • CNM $3.81
  • P/E Ratio
  • VKTX N/A
  • CNM $24.11
  • Revenue Growth
  • VKTX N/A
  • CNM 8.24
  • 52 Week Low
  • VKTX $17.23
  • CNM $37.22
  • 52 Week High
  • VKTX $99.41
  • CNM $62.15
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 35.23
  • CNM 59.62
  • Support Level
  • VKTX $39.09
  • CNM $49.91
  • Resistance Level
  • VKTX $43.48
  • CNM $51.75
  • Average True Range (ATR)
  • VKTX 2.15
  • CNM 1.51
  • MACD
  • VKTX 0.10
  • CNM -0.29
  • Stochastic Oscillator
  • VKTX 28.04
  • CNM 49.48

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About CNM Core & Main Inc.

Core & Main Inc is a specialty distributor focusing on water, wastewater, storm drainage, and fire protection products and services. Catering to municipalities, private water companies, and contractors, it serves municipal, non-residential, and residential markets nationwide. Its diverse product line includes pipes, valves, fittings, storm drainage products, fire protection products, and meter products. Revenue is primarily generated from pipes, valves, and fittings. The company operates across three construction sectors: municipal, non-residential, and residential, contributing to reliable infrastructure development nationwide.

Share on Social Networks: